Prevention of Gram-negative translocation reduces the severity of hepatopulmonary syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 4, 2002, Pages 514-517

  Rabiller, Anne ^a,b   Nunes, Hilario ^a,b   Lebrec, Didier ^a,b   Tazi, Khalid A ^a,b   Wartski, Myriam ^a,b   Dulmet, Elisabeth ^a,b   Libert, Jean Marie ^a,b   Mougeot, Christine ^a,b   Moreau, Richard ^a,b   Mazmanian, Michel ^a,b   Humbert, Marc ^a,b   Hervé, Philippe ^a,b  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

Bacterial translocation; Experimental cirrhosis; Hepatopulmonary syndrome; Macrophage; Nitric oxide synthase

Indexed keywords

ALBUMIN; NITRIC OXIDE SYNTHASE; NORFLOXACIN; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BILIARY CIRRHOSIS; BRAIN SCINTISCANNING; COMMON BILE DUCT; CONTROLLED STUDY; ENZYME ACTIVITY; GRAM NEGATIVE BACTERIUM; HEPATOPULMONARY SYNDROME; INTESTINE FLORA; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS OXYGEN TENSION; LUNG CIRCULATION; MACROPHAGE; MALE; MICROVASCULATURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASODILATATION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL TRANSLOCATION; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMODYNAMIC PROCESSES; HEPATOPULMONARY SYNDROME; LIGATION; LIVER CIRRHOSIS; MACROPHAGES, ALVEOLAR; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NORFLOXACIN; PULMONARY CIRCULATION; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX;

EID: 0037102354     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200201-027OC     Document Type: Article

References (25)

1. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric contractility
2. Effect of selective bowel decontamination with norfloxacine on spontaneous bacterial peritonitis, translocation, and survival in an animal model of liver cirrhosis
3. Gut barrier failure in experimental jaundice
4. Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease
5. Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats
6. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats
7. Mediators, cytokines, and growth factors in liver-lung interactions
8. Macrophage control of inflammation: Negative pathways of regulation of inflammatory cytokines
9. Pulmonary circulatory dysfunction in rats with biliary cirrhosis: An animal model of the hepatopulmonary syndrome
10. Common bile duct ligation in the rat: A model of intrapulmonary vasodilatation and hepatopulmonary syndrome
11. Pulmonary vascular disorders in portal hypertension
12. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-control trial
13. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination: A retrospective study of 22 spontaneous bacterial peritonitis episodes
14. Hemodynamic characterization of chronic bile duct-ligated rats: Effect of pentobarbital sodium
15. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme
16. Increased endothelial nitric oxide synthase activity in the hyperhemic vessels of portal hypertensive rats
17. Enhanced nitric oxide synthase activity in portal hypertensive rabbits
18. A rapid and sensitive method for the quantification of microGram quantities of protein utilizing the principle of protein-dye binding
19. Activation of human endothelial cells by viable or heat-killed Gram-negative bacteria requires soluble CD14
20. Clinical Gram-positive sepsis: Does it fundamentally differ from Gram negative bacterial sepsis?
21. Differential induction of NO synthesis by Gram-positive and Gram-negative bacteria and their components in bovine monocyte-derived macrophages
22. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilatation of portal hypertension
23. Novel presentation and approach to management of hepatopulmonary syndrome with the use of antimicrobial agents
24. An evaluation of lung uptake of colloid during liver imaging
25. Lung uptake of 99 mTc-sulfur colloid